Gyroscope Overview
- Year Founded
-
2016
- Status
-
Acquired/Merged
- Employees
-
72
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$1.5B
Gyroscope General Information
Description
Developer of genetically-defined therapies designed to serve patients suffering from retinal diseases. The company's gene therapy helps to treat a leading cause of blindness and dry age-related macular degeneration (AMD), thereby providing patients with one-time therapy delivered under the retina.
Contact Information
Website
www.gyroscopetx.com(Operating Subsidiary)
Corporate Office
- Rolling Stock Yard
- 6th Floor, 188 York Way
- London N7 9AS
- England, United Kingdom
Corporate Office
- Rolling Stock Yard
- 6th Floor, 188 York Way
- London N7 9AS
- England, United Kingdom
Gyroscope Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Merger/Acquisition | 17-Feb-2022 | $1.5B | Completed | Clinical Trials - Phase 2 | ||
| 8. Later Stage VC | 08-Nov-2021 | Completed | Clinical Trials - Phase 2 | |||
| 7. IPO | 10-Jun-2021 | Cancelled | Clinical Trials - Phase 2 | |||
| 6. Later Stage VC (Series C) | 26-Mar-2021 | Completed | Clinical Trials - Phase 2 | |||
| 5. Early Stage VC (Series B) | 02-Sep-2019 | Completed | Clinical Trials - Phase 2 | |||
| 4. Grant | 01-Nov-2018 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series A) | 21-Mar-2018 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 12-May-2016 | $7.69M | $7.69M | Completed | Generating Revenue | |
| 1. University Spin-Out | 18-Apr-2016 | Completed | Startup |
Gyroscope Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C1 | ||||||||
| Series B | ||||||||
| Series A | 35,648,331 | $0.000014 | $1.39 | $1.39 | 1x | $1.39 | 23.9% |
Gyroscope Comparisons
Industry
Financing
Details
Gyroscope Competitors (46)
One of Gyroscope’s 46 competitors is Juventas Therapeutics, a Venture Capital-Backed company based in Cleveland, OH.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Juventas Therapeutics | Venture Capital-Backed | Cleveland, OH | ||||
| Exonate | Venture Capital-Backed | Cambridge, United Kingdom | ||||
| Spero Therapeutics | Formerly VC-backed | Cambridge, MA | ||||
| Prometheus Laboratories | Formerly VC-backed | San Diego, CA | ||||
| TearSolutions | Venture Capital-Backed | Charlottesville, VA |
Gyroscope Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Gyroscope Patents
Gyroscope Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202216569-D0 | Novel complement inhibitors related to complement receptor 1 (cr1), polynucleotides, vectors, and therapeutic use | Inactive | 07-Nov-2022 | ||
| GB-202114106-D0 | Complement receptor 1 polypeptides, vectors encoding therefore and therapeutic use | Inactive | 01-Oct-2021 | ||
| GB-202104148-D0 | Product | Inactive | 24-Mar-2021 | ||
| CA-3175283-A1 | Suprachoroidal injection device | Pending | 09-Feb-2021 | ||
| AU-2022221237-A1 | Suprachoroidal injection device | Pending | 09-Feb-2021 | A61F9/0026 |
Gyroscope Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Gyroscope Former Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Cambridge Enterprise | Corporate Venture Capital | Minority | ||
| Cambridge Innovation Capital | Venture Capital | Minority | ||
| Forbion | Venture Capital | Minority | ||
| Fosun Pharma | Corporation | Minority | ||
| Innovate UK | Accelerator/Incubator |
Gyroscope Acquisitions (1)
Gyroscope’s most recent deal was a Merger/Acquisition with Orbit Biomedical. The deal was made on 11-Apr-2019.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Orbit Biomedical | 11-Apr-2019 | Merger/Acquisition | Biotechnology |
Gyroscope FAQs
-
When was Gyroscope founded?
Gyroscope was founded in 2016.
-
Where is Gyroscope headquartered?
Gyroscope is headquartered in London, United Kingdom.
-
What is the size of Gyroscope?
Gyroscope has 72 total employees.
-
What industry is Gyroscope in?
Gyroscope’s primary industry is Drug Discovery.
-
Is Gyroscope a private or public company?
Gyroscope is a Private company.
-
What is the current valuation of Gyroscope?
The current valuation of Gyroscope is .
-
What is Gyroscope’s current revenue?
The current revenue for Gyroscope is .
-
How much funding has Gyroscope raised over time?
Gyroscope has raised $285M.
-
Who are Gyroscope’s investors?
Cambridge Enterprise, Cambridge Innovation Capital, Forbion, Fosun Pharma, and Innovate UK are 5 of 9 investors who have invested in Gyroscope.
-
Who are Gyroscope’s competitors?
Juventas Therapeutics, Exonate, Spero Therapeutics, Prometheus Laboratories, and TearSolutions are some of the 46 competitors of Gyroscope.
-
When was Gyroscope acquired?
Gyroscope was acquired on 17-Feb-2022.
-
Who acquired Gyroscope?
Gyroscope was acquired by Novartis.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
